CAP Accreditation is Awarded to Clinical Laboratories Meeting the Highest Standards in Laboratory Practices
Research Triangle Park, NC and Cambridge, UK, April 18, 2019 -- Inivata, a leader in liquid biopsy, today announces that it has received Accreditation from the College of American Pathologists (CAP) for its CLIA laboratory in Research Triangle Park, North Carolina. The CAP Accreditation is awarded to laboratories which meet stringent quality, accuracy and consistency requirements.
The CAP Laboratory Accreditation Program began in the early 1960s and is widely recognized as being…
16 April 2019 – Genomics England has announced today the successful completion of the first phase of its collaboration with Inivata and Thermo Fisher Scientific. This is part of a pilot project, undertaken by Genomics England in collaboration with industry, to:
• assess the suitability of circulating tumour DNA (ctDNA) samples collected by the NHS during the 100,000 Genomes Project• perform objective technology evaluation of the various market offerings in liquid biopsy• generate evidence for the potential consideration of such technology implementation in future routine healthcare for better…
Further Milestone from Janssen on NDA Approval by the US FDA of BALVERSA™ (erdafitinib) for the Treatment of Urothelial Cancer
Cambridge, UK, 12 April 2019, Astex Pharmaceuticals (Astex), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that it has received a milestone payment from Janssen Pharmaceutica N.V. (Janssen). This follows the United States Food and Drug Administration’s (FDA) accelerated review and approval of a Janssen New Drug Application (NDA) for…
Businesses across East Anglia are turning to placement students from the University of East Anglia (UEA) to help innovate and grow their organisations.
Increasing numbers of businesses are hosting placement students with many offering them permanent positions when they graduate.
What is a placement student and how could they benefit you? A placement is an opportunity to recruit a student to work with you and your organisation for 9 – 14 months. It’s more than just work experience or shadowing; a placement student can bring real benefits to your business. You gain an…
BILLINGHAM, England, April 11, 2019 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System.
The introduction of new single step cloning technology, in combination with the new Apollo X host cell line has allowed development timelines to be significantly reduced. The Apollo…
AMSBIO announces XerumFree™ - a new concept in cell culture that allows you to culture cells without the use of serum.XerumFree™ has been developed taking into account what is missing in traditional basal cell culture media to sustain growth of all cell types, which is a nutritional approach at the cellular level. Containing no animal or human derived material, XerumFree™ is a serum replacement for all cell culture practices that is chemically defined thereby avoiding lot-to-lot variations and eliminating the need for testing new batches of serum. Since XerumFree™ does not contain…
Detachin™ Cell Detachment Solution from AMSBIO is a high-performance alternative to Trypsin/EDTA for detaching adherent cells from in vitro growth vessels. Detachin™ provides rapid, gentle, and effective detachment of a wide variety of adherent cells, including primary cells, from all commercially available tissue culture plasticware.
Proven to provide a consistent, safe, and efficient method for cell detachment and dissociation, Detachin™ contains protease and collagenase activities in an isotonic, phosphate buffer solution with EDTA. It has been tested successfully on many different primary…
AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.
Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the best negative controls to quickly and confidently prove an antibody’s specificity for a target of interest and ensure reproducibility.
Generated in the most widely used HEK293T, HeLa, and A549…
AMSBIO is a leading supplier of gold, silver and platinum coated substrates for nanotechnology researchers looking to use these surfaces to characterize self-assembled monolayers using atomic force microscopy (AFM), or scanning tunneling microscopy (STM).
Gold, silver and platinum surfaces offer a clean, near atomically-flat surface that is ideal for applications in nanotechnology, such as studies on self-assembly, single-molecule imaging, nano- or micro-contact printing, DNA origami, or nanophotonics.
Deposited under high vacuum (10-8 Torr) with 99.999% purity noble metal…
AMSBIO offers an unmatched portfolio of over 2000 tissue microarrays (TMAs), one of the best sample formats for rapid detection of cellular localization of RNA and protein expression.Recently AMSBIO introduced US Food & Drug Administration (FDA) standard TMAs for human, mouse and rat to its portfolio. Designed in close conformance with FDA guidelines, this range meets the requirements for tissue cross-reactivity studies required for therapeutic and diagnostic antibody and antibody-like molecules validation. Each array slide features the FDA recommended list of normal tissue types in…